| Literature DB >> 32190081 |
Qing Miao1, Ruihai Wang1, Dong Bai1, Xin Xue1, Jing Xu1, Xiaoxin Sun1, Limei Liu1.
Abstract
Garlic has been proven effective in the prevention and treatment of atherosclerosis (AS), which is widely used as a food and medicine by people in daily life. Garlic saponins are the main active nonsulfur compounds of garlic, which have a variety of pharmacological activities against cardiovascular diseases. In this study, the antiatherosclerosis properties and mechanism of total saponins of garlic (TSG) in rats were explored. The AS animal model was established by a combination of high-fat feeding, intraperitoneal injection of vitamin D3, and ovalbumin-induced inflammation in SD rats. Then, the atherosclerotic rats were gavaged daily by TSG for 4 weeks. Administration of TSG markedly decreased atherosclerotic lesions in the aorta of atherosclerotic rats. TSG restored the serum lipid profile by significantly decreasing the lipid levels and had effective antioxidation by inhibiting the content of malondialdehyde (MDA) and restoring the reduced activity of superoxide dismutase (SOD). Additionally, the ratio of thromboxane B2 (TXB2) and 6-keto-prostaglandin F1α (6-keto-PGF1α ) could be maintained in a relatively stable dynamic balance after administration of TSG to maintain the vascular homeostasis. In summary, TSG had therapeutic effects on AS, which are promising as functional foods or nutraceuticals for the prevention and treatment of AS.Entities:
Year: 2020 PMID: 32190081 PMCID: PMC7064851 DOI: 10.1155/2020/3683659
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
Figure 1Effects of different treatment on histopathological changes in the aortas of rats: (a) the control group, (b) model group, (c) positive control group, (d) 0.6 g/Kg TSG group, (e) 1.2 g/Kg TSG group, and (f) 2.4 g/Kg TSG group.
Effects of TSG on serum lipid levels in rats.
| Group | TC (mM) | TG (mM) | HDL-C (mM) | LDL-C (mM) |
|---|---|---|---|---|
| Control | 1.684 ± 0.211 C | 0.087 ± 0.012 AB | 1.332 ± 0.220 | 0.181 ± 0.073 C |
| Model | 4.542 ± 0.987 A | 0.108 ± 0.025 A | 1.553 ± 0.380 | 0.770 ± 0.322 A |
| Simvastatin | 2.950 ± 0.584 B | 0.069 ± 0.018 B | 1.709 ± 0.290 | 0.359 ± 0.162 B |
| 0.6 g/kg TSG | 3.463 ± 0.633 B | 0.083 ± 0.016 AB | 1.599 ± 0.344 | 0.470 ± 0.323 AB |
| 1.2 g/kg TSG | 3.164 ± 0.755 B | 0.084 ± 0.023 AB | 1.557 ± 0.260 | 0.334 ± 0.196 B |
| 2.4 g/kg TSG | 3.143 ± 0.776 B | 0.074 ± 0.019 B | 1.468 ± 0.196 | 0.225 ± 0.138 B |
Data are presented as mean ± SD, (n = 12). Values with different capital letters in a column are significantly different (p < 0.05) from each other.
Figure 2Effects of TSG on MDA (a) and SOD (b) levels in rats. Data are presented as mean ± SD, (n = 12). Values with different capital letters in a column are significantly different (p < 0.05) from each other.
Figure 3Effects of TSG on TXB2 (a) and 6-keto-PGF1 (b) levels in rats. Data are presented as mean ± SD, (n = 12). Values with different capital letters in a column are significantly different (p < 0.05) from each other.